Weight loss drug is not taking easy way out

A new peer-reviewed study based on data from nearly 2M individuals highlights a wide range of clinical benefits and risks, ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...
Over 2 million people were included in new research to test these drugs against 175 different health outcomes.
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...
GLP-1 weight loss drugs - such as Wegovy and Mounjaro - may reduce risk of conditions including Alzheimer’s disease and ...
Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...